Legence Corp. Class A Common stock
NASDAQ:LGNEngineering & Construction
-$0.32 today
- Market cap
- $4.82B
- Beta
- 2.93
- P/E (TTM)
- -254.3
- EPS (TTM)
- -$0.33
Volume 1.58M
Average 1.71M
LGN Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Legence Corp. Class A Common stockNASDAQ: LGN
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Research & Development vs competitors
How LGN compares with its peers on the latest reported figures
- LGN's LTM Sep 2026 research & development of $0 is the highest of the 5 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for LGN, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
LGNLegence Corp. Class A Common stock | LTM Sep 2026 | $0 | — | — | 0.0% |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding LGN) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for LGN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.25B | 1.62B | 2.1B | 2.55B |
| Cost of Revenue | 1.01B | 1.3B | 1.67B | 2.01B |
| Gross Profit | 233.71M | 315.15M | 428.64M | 535.93M |
| Gross Margin | 18.7% | 19.5% | 20.4% | 21.0% |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 142.05M | 186.06M | 252.67M | 342.63M |
| Operating Expenses | 257.95M | 304.89M | 370.2M | 442.99M |
| Depreciation & Amortization | 93.02M | 92.8M | 110.85M | 114.29M |
| EBITDA | 69.2M | 107.05M | 156.62M | 160.92M |
| EBITDA Margin | 5.6% | 6.6% | 7.5% | 6.3% |
| Operating Income | (24.25M) | 10.26M | 58.44M | 92.93M |
| Operating Margin | -1.9% | 0.6% | 2.8% | 3.6% |
| Interest Income | 236K | 4.25M | 5.46M | 4.49M |
| Interest Expense | 50.84M | 68.2M | 25.54M | 101.78M |
| Other Income / Expenses | (50.41M) | (64.2M) | (38.21M) | (148.08M) |
| Income Before Tax | (74.66M) | (53.94M) | 20.23M | (55.14M) |
| Pre-Tax Margin | -6.0% | -3.3% | 1.0% | -2.2% |
| Income Tax Expense | 7.61M | (7.92M) | 2.81M | 22.16M |
| Net Income | (82.27M) | (46.03M) | 9.72M | (59.78M) |
| Net Margin | -6.6% | -2.8% | 0.5% | -2.3% |
| EPS (Basic) | (0.81) | (0.45) | 0.10 | (1.01) |
| EPS (Diluted) | (0.81) | (0.45) | 0.10 | (1.01) |
| Weighted Avg Shares | 58.51M | 58.51M | 58.51M | 59.38M |
| Weighted Avg Shares (Diluted) | 58.51M | 58.51M | 58.51M | 59.38M |
Legence Corp. Class A Common stock
NASDAQ:LGN
Intrinsic Alpha fair value
Locked
Current Price
$34.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.